Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
11/2003
11/13/2003US20030212138 Synergistic mixture; analgesics, antiinflammatory agents, cardiovascular disorders, anticancer agents
11/13/2003US20030212091 Aryl ether substituted imidazoquinolines
11/13/2003US20030212082 Controlling neovascularization; angiogenesis inhibitors; therapy for strokes, cardiovascular disorders; antitumor agents; antidiabetic agents; antiarthritic agents; psoriasis
11/13/2003US20030212081 Bicyclic heteroaromatic compounds useful as LH agonists
11/13/2003US20030212064 Triazolotriazinones and the use thereof
11/13/2003US20030212062 Morpholinone and morpholine derivatives and uses thereof
11/13/2003US20030212057 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
11/13/2003US20030212055 Cinnoline compounds
11/13/2003US20030212026 Induce immunology response
11/13/2003US20030212012 Prevention labor contraction; urogenital disorders
11/13/2003US20030211986 Protein a compositions and methods of use
11/13/2003US20030211969 Administering activated protein c; controlling blood coagulation
11/13/2003US20030211563 Human testis specific serine/threonine kinase 1 & 2
11/13/2003US20030211513 Intracellular signaling proteins
11/13/2003US20030211165 Anticancer agents; mixture of hydrophilic, crosslinked polymer and drugs
11/13/2003US20030211161 Anhydrous mixture of polyalcohol and insulation gel; dysmenorrhea
11/13/2003US20030211040 Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain
11/13/2003CA2484599A1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
11/13/2003CA2484582A1 Bombesin antagonists
11/13/2003CA2484551A1 Smart pro-drugs of serine protease inhibitors
11/13/2003CA2484329A1 Warming and nonirritating anhydrous lubricant compositions
11/13/2003CA2484258A1 Soya cell strains with high isoflavone content
11/13/2003CA2484173A1 4-azasteroid derivatives as androgen receptor modulators
11/13/2003CA2484162A1 Imidazo-triazine derivatives as ligands for gaba receptors
11/13/2003CA2483846A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
11/13/2003CA2483806A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003CA2483787A1 Melanocortin receptor ligands
11/13/2003CA2483573A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003CA2482780A1 Apparatus and method for delivery of constrained beneficial bacteria to the vaginal tract
11/12/2003EP1360964A1 Use of galanin-like peptide
11/12/2003EP1360279A2 Novel form of the phgpx protein as a diagnostic marker for male infertility
11/12/2003EP1360186A2 Carboline derivatives
11/12/2003EP1360185A2 Carboline derivatives
11/12/2003EP1360174A1 Phenethanolamine derivatives for treatment of respiratory diseases
11/12/2003EP1360169A2 Succinate salt of o-desmethyl-venlafaxine
11/12/2003EP1359920A2 Methods and formulations for the treatment of female sexual dysfunction
11/12/2003EP1359916A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/12/2003EP1359907A2 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors
11/12/2003EP1359906A2 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
11/12/2003EP1235809B1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments
11/12/2003EP0752883B1 Use of mcp-1 for inducing ripening of the cervix
11/12/2003EP0513336B1 New variants derived from interferons of type i, production process thereof and their applications
11/12/2003CN1455781A Discrimination between GnRH-Ôàáand GnRH-Ôàí"
11/12/2003CN1455681A Contraception process and administration for same
11/12/2003CN1455676A Chinese-herb composition and method for preparing same
11/12/2003CN1455667A Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects
11/12/2003CN1454901A Gynaecological anti-infective specificity IgY and its combined preparation
11/12/2003CN1454634A Capsule for curing asynodia, spermatorrhea, nephralgia and osphyalgia
11/12/2003CN1454607A Medicine for curing cervicitis and preparing method thereof
11/12/2003CN1454602A High water-soluble povidone-iodine cream
11/12/2003CN1127506C New compound for treating asgnodia
11/12/2003CN1127488C Compouds with growth hormone releasing properties
11/12/2003CN1127339C Use of carbonic anhydrase inhibitor acetazolamide in preparing male contraceptives
11/12/2003CN1127338C Anti-vaginitis composition for topiical use comprising one or move anti-vaginitis medicaments and one or more local anaesthetics
11/11/2003US6646170 Intermediates for the synthesis of ether compounds
11/11/2003US6646137 Non-peptide GnRH agents
11/11/2003US6646004 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
11/11/2003US6645997 Agonists of peroxisome proliferator activated receptor (PPAR) alpha and/or gamma
11/11/2003US6645977 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors
11/11/2003US6645974 Androgen receptor modulators and methods for use thereof
11/11/2003US6645968 Potassium channel openers
11/11/2003US6645967 Arylpiperazines having activity at the serotonin 1A receptor
11/11/2003US6645958 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
11/11/2003US6645951 Benzopyran or thiobenzopyran derivatives
11/11/2003US6645531 Halting, diminishing, or inhibiting the growth of at least one of a bacterium, a fungus; a parasitic microbe, and a virus, which method comprises administering at least one electron active compound
11/11/2003CA2290332C Optically pure androgen mediator
11/11/2003CA2144967C Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
11/11/2003CA2091440C 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as alpha adrenergic agents
11/11/2003CA2055637C Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia
11/06/2003WO2003091437A1 Chimeric camp factors for vaccination against streptococcus infection
11/06/2003WO2003091259A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
11/06/2003WO2003091257A1 [1,4]DIAZOCINO [7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS
11/06/2003WO2003091251A1 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents
11/06/2003WO2003091250A1 [1,4]diazepino[6,7,1-ij]quinoline derivatives as anti psychotic and antiobesity agents
11/06/2003WO2003091239A1 Estrogen receptor modulators
11/06/2003WO2003091236A1 Imidazolinylmethyl aralkylsulfonamides
11/06/2003WO2003091225A1 Substituted pyrazine derivatives
11/06/2003WO2003091204A1 Phenethanolamine derivatives
11/06/2003WO2003090755A1 Treatment of hypertension in women receiving hormone replacement therapy
11/06/2003WO2003090752A1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/06/2003WO2003090751A1 Pyrimidine-2, 4, 6-trione metallo-proteinase inhibitors
11/06/2003WO2003090748A1 Use of compounds having ccr antagonism
11/06/2003WO2003090714A1 Method for the production of crystals, crystals obtained by said method, and use thereof in pharmaceutical formulations
11/06/2003WO2003090705A1 Biologically active compounds for the modification of bodily odours
11/06/2003WO2003090672A2 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
11/06/2003WO2003090671A2 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
11/06/2003WO2003079981A3 Bioadhesive drug delivery system
11/06/2003WO2003057166A3 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
11/06/2003WO2003039455A3 Methods of treating endometreosis
11/06/2003WO2003035626A3 Azole derivatives and pharmaceutical compositions containing them
11/06/2003WO2003035005A3 Heteroindanes: a new class of potent cannabimimetic ligands
11/06/2003WO2003031939A3 Protein modification and maintenance molecules
11/06/2003WO2003027263A3 Proteins associated with cell growth, differentiation, and death
11/06/2003WO2003018049A3 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
11/06/2003WO2003016270A3 Selective estrogen receptor modulators
11/06/2003WO2002094799A3 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/06/2003WO2002076979A8 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
11/06/2003WO2002072631A3 Mhc molecule constructs and their usesfor diagnosis and therapy
11/06/2003WO2002072100A3 Pharmaceutical composition containing pde v inhibitors and surfactants
11/06/2003WO2002059117A8 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
1 ... 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 ... 557